IBDEI0HC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8077,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,8077,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,8077,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,8078,0)
 ;;=605.^^35^480^42
 ;;^UTILITY(U,$J,358.3,8078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8078,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,8078,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,8078,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,8079,0)
 ;;=601.0^^35^480^44
 ;;^UTILITY(U,$J,358.3,8079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8079,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,8079,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,8079,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,8080,0)
 ;;=590.10^^35^480^46
 ;;^UTILITY(U,$J,358.3,8080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8080,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,8080,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,8080,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,8081,0)
 ;;=590.00^^35^480^47
 ;;^UTILITY(U,$J,358.3,8081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8081,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,8081,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,8081,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,8082,0)
 ;;=788.7^^35^480^54
 ;;^UTILITY(U,$J,358.3,8082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8082,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,8082,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,8082,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,8083,0)
 ;;=131.02^^35^480^57
 ;;^UTILITY(U,$J,358.3,8083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8083,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,8083,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,8083,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,8084,0)
 ;;=597.80^^35^480^55
 ;;^UTILITY(U,$J,358.3,8084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8084,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,8084,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,8084,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,8085,0)
 ;;=788.41^^35^480^58
 ;;^UTILITY(U,$J,358.3,8085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8085,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,8085,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,8085,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,8086,0)
 ;;=788.31^^35^480^62
 ;;^UTILITY(U,$J,358.3,8086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8086,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,8086,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,8086,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,8087,0)
 ;;=788.20^^35^480^63
 ;;^UTILITY(U,$J,358.3,8087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8087,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,8087,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,8087,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,8088,0)
 ;;=112.2^^35^480^66
 ;;^UTILITY(U,$J,358.3,8088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8088,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,8088,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,8088,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,8089,0)
 ;;=600.01^^35^480^5
 ;;^UTILITY(U,$J,358.3,8089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8089,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,8089,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,8089,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,8090,0)
 ;;=600.10^^35^480^40
 ;;^UTILITY(U,$J,358.3,8090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8090,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,8090,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,8090,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,8091,0)
 ;;=585.9^^35^480^8
 ;;
 ;;$END ROU IBDEI0HC
